Polymeric Micelles, a Promising Drug Delivery System to Enhance Bioavailability of Poorly Water-Soluble Drugs
Open accessThe DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
Abstract
Oral administration is the most commonly used and readily accepted form of drug delivery; however, it is find that many drugs are difficult to attain enough bioavailability when administered via this route. Polymeric micelles (PMs) can overcome some limitations of the oral delivery acting as carriers able to enhance drug absorption, by providing (1) protection of the loaded drug from the harsh environment of the GI tract, (2) release of the drug in a controlled manner at target sites, (3) prolongation of the residence time in the gut by mucoadhesion, and (4) inhibition of efflux pumps to improve the drug accumulation. To explain the mechanisms for enhancement of oral bioavailability, we discussed the special stability of PMs, the controlled release properties of pH-sensitive PMs, the prolongation of residence time with mucoadhesive PMs, and the P-gp inhibitors commonly used in PMs, respectively. The primary purpose of this paper is to illustrate the potential of PMs for delivery of poorly water-soluble drugs with bioavailability being well maintained.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Schematic representation of the mechanisms involved in the absorption of exogenous drugs in the small intestine. (a) Transcellular transport; (b) active transport; (c) facilitated diffusion; (d) receptor-mediated endocytosis; (e) paracellular transport; (f) pinocytosis [3].](https://figures.cochat.ai/paper-figures/f760f35972f34f1c8e324112b058d11c/polymeric-micelles-a-promising-drug-delivery-system-to-enhance-bioavailability-figure-1.jpg)


![Figure 4 Pluronic block copolymers available from BASF (Wyandotte, MI, USA) contain two hydrophilic EO blocks and a hydrophobic PO block [167].](https://figures.cochat.ai/paper-figures/292163f5bd3e4a15b3eb9e18032f118f/polymeric-micelles-a-promising-drug-delivery-system-to-enhance-bioavailability-figure-4.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ABC Transporters: From Microorganisms to Man
Higgins, C. F. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.000435 · Cited by 3,985 · cited 3×
“Pgp is a 170-kDa membrane transporter which is part of the ATP-binding cassette (ABC) [150].”
BackgroundSolid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759 · cited 2×
“Several strategies have been proposed such as micronization, complexation, formation of solid solutions, microemulsification, and novel drug delivery systems, including nanoparticles, lipid-based vesicles, and micelles [15–18].”
BackgroundDrug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734 · cited 1×
“Besides, approximately 40% of currently marketed immediate-release oral drugs are considered practically insoluble (solubility less than 100 μg/mL) in water [6, 7].”
BackgroundImpact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348 · cited 2×
“macromolecules [12, 13].”
A review of stimuli-responsive nanocarriers for drug and gene delivery
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,155 · cited 2×
“Blends of this polymer with polyethylacrylate (PMAA-PEA) and polymethacrylate (PMAA-PMA) can be tailored to dissolve in specific pH ranges corresponding to specific locations in the GI tract [100–102].”
BackgroundMicellization of block copolymers
Riess, G. (2003) · Progress in Polymer Science · doi:10.1016/s0079-6700(03)00015-7 · Cited by 1,953 · cited 1×
“PMs are self-assembled core-shell nanostructures formed in an aqueous solution consisting of amphiphilic block copolymers (see Figure 2) [35, 36].”
BackgroundMucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815 · cited 1×
“Mucoadhesion can be obtained by the building of either nonspecific interactions with the mucosal surface, such as covalent bonds, ionic bonds, hydrogen bonding, and van der Waals’ interactions [117], or specific interactions by functionalizing polymers with targeting ligands (e.”
BackgroundOral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623 · cited 1×
“Intrinsic properties of drugs such as poor stability in the gastric environment, lowmucosal permeability, and low solubility in the mucosal fluids will contribute to low absorption [26, 27].”
BackgroundPluronic® block copolymers as novel polymer therapeutics for drug and gene delivery
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00009-3 · Cited by 1,474 · cited 3×
“Poly(propylene oxide) (PPO) [53, 59] which belongs to Pluronics, poly(esters) such as poly(lactic acid) (PLA) [60], hydrophobic poly(amino acids) [61], copolymers of lactic acid and glycolic acids [62, 63], and poly(caprolactone) (PCL) [64], which are regarded as the”
BackgroundMethodCone, R. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.008 · Cited by 1,459 · cited 1×
“The luminal surface of mucosal tissues is protected by a highly viscoelastic layer [110], and the protective coatings rapidly remove foreign particles from the GI tract which probably lead to low bioavailability.”
Background
Research works printed but not linked: 2
- Lee ES Shin HJ Na K Bae YH Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization Journal of Controlled Release 2003 90 3 363 374 2-s2.0-0038106270 12880703 · DOI · Paper page
- Mo R Jin X Li N The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles Biomaterials 2011 32 20 4609 4620 2-s2.0-79955522520 21440934 · DOI · Paper page
Cited by
Items 601–620 of 620
Tinku, Prajapati, A. K., Gautam, P., & Choudhary, S. (2026) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2026.129810
Singh, S., Mehra, A., Garg, G., Bhati, P., Roy, S., Priya, K., Ashraf, M. T., & Khan, A. A. (2026) · Biophysica · doi:10.3390/biophysica6050102
Nonmetallic nanoparticles: A therapeutic platform for nonmalignant disorders
Mirmasoudi, S. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33641-6.00021-x
Nonmetallic stimuli-responsive nanocarriers in the treatment of noncancerous disease
Mirmasoudi, S. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33641-6.00005-1
From nanoscale to clinic: The growing impact of nanotechnology in translational drug delivery
Vargas, R., Martos-Kikut, F., Martínez-Martínez, N., Lara-Guerrero, E., Lizano-Barrantes, C., Molina, J. A. P., Romero-Obón, M., Rouaz-El-Hajoui, K., García‐Montoya, E., Pérez‐Lozano, P., et al. (2026) · ADMET & DMPK · doi:10.5599/admet.3495 · Cited by 1
“The micellar constituents are organized into spherical structures, with hydrophilic groups surrounding the hydrophobic core, thereby encapsulating hydrophobic drugs within their core [68,80].”
Lathamani, L., Sathiya, S., J., S. T., Padmasri, E., Sheeba, J., Shobica, K., Sowmiya, K., Dhanasekar, J., Pawar, S. D., & Arvinthkumar, R. (2026) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2026.v86i5.001
Nanomicelles-based drug delivery systems as for targeted therapy of colon cancer
Paul, A., Ali, A., Prabhakar, P. K., & Upadhyay, T. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40443-6.00018-0
Azhar, M., Malviya, R., Chandra, P., Sridhar, S. B., Shareef, J., Wadhwa, T., & Arockiam, D. (2026) · Journal of Biological Engineering · doi:10.1186/s13036-026-00744-8
Karim, M. R., Hossain, M. A., Shamim, M., Hosen, M. R., Hossain, M. S., Hossaın, M. T., Akhter, M. S., Simran, K. T., & Islam, M. S. (2026) · Chemistry & Biodiversity · doi:10.1002/cbdv.71574
“Water solubility is particularly important for current oral medication administration since more soluble medicines have higher bioavailability and absorption rates [80, 81].”
Applying a nano-micelle based method for delivering atropine base from a contact lensPreprint
Aziz, M. A., Maulvi, F. A., Kuppusamy, R., Mazumder, K., Hui, A., Stapleton, F. J., & Willcox, M. D. P. (2026) · Research Square · doi:10.21203/rs.3.rs-10640204/v1
Nanotherapeutics in the treatment of cancer: transforming cancer care
Rad, M. K., Razani, E., & Bashash, D. (2026) · European Journal of Cancer Care · doi:10.48130/ejcc-0026-0007
AI‐Driven Rational Design of Nanotherapeutics for Pancreatic Ductal Adenocarcinoma
Choo, S., Chae, K., Lee, J., Kim, I., & Lee, S. S. (2026) · Medicinal Research Reviews · doi:10.1002/med.70105
Overcoming Solubility and Aggregation: Water-Soluble Porphyrins in Modern Phototherapy
Gayathri, M. P., Powar, J. P., & Babu, B. (2026) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6c00451
พอลิเมอริกไมเซลล์เพื่อการนำส่งยา : การบรรจุยาด้วยวิธีทางกายภาพ และปัจจัยที่ส่งผลต่อประสิทธิภาพ
วรพัฒน์ผดุง, ฐ., & โอปณะโสภิต, ป. (2015) · Thai Phai Satchayaniphon · doi:10.69598/tbps.9.2.62-73
Smart Dental Materials and their Antimicrobial Applications: An Updated Review
AlQahtani, R. A. (2024) · Review of Contemporary Philosophy
Can, R. N. (2023) · Yildiz Technical University - AVESIS
Development of a nystatin-loaded micellar system for oral mucoadhesion
Sarpong, N. O. A. (2019) · Nelson Mandela University Research Repository
Thalluri, C., Bukke, S. P. N., Medhi, J., Vasam, M., Vidiyala, N., Sunkishala, P., & Samanthula, K. S. (2026) · Assay and Drug Development Technologies · doi:10.1177/1540658x261502046
Alsofany, J. M., Elsalhy, S., Naggar, E. E. E., Saleh, A. M., Elazab, E. F., Ahmed, A. A., El-Sayed, E. K., Elsherbiny, M. E., Atawia, R. T., & Tantawy, N. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.109096
Polymer-based micelles and fibers
Flores‐Rojas, G. G., Gómez-Lázaro, B., Pérez-Carrillo, L. A., Bucio, E., Vera‐Graziano, R., & Mendizábal, E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33052-0.00001-1
Metadata
- Authors
- Xu, W., Ling, P., & Zhang, T.
- Affiliations
- Shandong University (CN)
- Institute of Biopharmaceuticals of Shandong Province, Jinan 250101, China
- Corresponding author
- Ling, Peixue
- ORCID
- Venue
- Journal of Drug Delivery
- Publisher
- Wiley
- Published
- 2013-06-27
- Volume
- 2013
- Pages
- 1-15
- ISSN
- 2090-3014 (ISSN-L)
- 2090-3022
- PMC
- PMC3712247
- OpenAlex
- W2061955697
- Cited by
- 595
- References
- 181
- Citations by year
- 2026: 32 · 2025: 47 · 2024: 50 · 2023: 60 · 2022: 74 · 2021: 70 · 2020: 56 · 2019: 49 · 2018: 41 · 2017: 43 · 2016: 32 · 2015: 22 · 2014: 18 · 2013: 1
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Drug Delivery (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- University of California, Davis
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- polymeric micelles, oral drug delivery, bioavailability enhancement, poorly water-soluble drugs, mucoadhesion, pH-responsive micelles, controlled drug release, P-glycoprotein inhibition, efflux pump inhibition, drug stability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.